131 related articles for article (PubMed ID: 20934245)
21. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
22. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
23. Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader.
Zhao Y; Zhao C; Lu J; Wu J; Li C; Hu Z; Tian W; Yang L; Xiang J; Zhou H; Deng Z; Huang J; Hong K
Pharmacol Res; 2019 Aug; 146():104294. PubMed ID: 31175940
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y
Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982
[TBL] [Abstract][Full Text] [Related]
25. Antiestrogenic Activity of the Xi-Huang Formula for Breast Cancer by Targeting the Estrogen Receptor α.
Hao J; Jin Z; Zhu H; Liu X; Mao Y; Yang X; Gao L; Liu D; Chen D; Wu X
Cell Physiol Biochem; 2018; 47(6):2199-2215. PubMed ID: 29975948
[TBL] [Abstract][Full Text] [Related]
26. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
27. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
28. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
Yang H; Chen D; Cui QC; Yuan X; Dou QP
Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429
[TBL] [Abstract][Full Text] [Related]
29. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
30. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.
Near RI; Zhang Y; Makkinje A; Vanden Borre P; Lerner A
J Cell Physiol; 2007 Sep; 212(3):655-65. PubMed ID: 17427198
[TBL] [Abstract][Full Text] [Related]
31. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
Hua KT; Way TD; Lin JK
Mol Carcinog; 2006 Aug; 45(8):551-60. PubMed ID: 16637063
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
33. Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells.
Li Q; Wu L; Oelschlager DK; Wan M; Stockard CR; Grizzle WE; Wang N; Chen H; Sun Y; Cao X
J Biol Chem; 2005 Jul; 280(29):27022-8. PubMed ID: 15886208
[TBL] [Abstract][Full Text] [Related]
34. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
Belguise K; Guo S; Sonenshein GE
Cancer Res; 2007 Jun; 67(12):5763-70. PubMed ID: 17575143
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
36. Suppression of cell proliferation and regulation of estrogen receptor alpha signaling pathway by arsenic trioxide on human breast cancer MCF-7 cells.
Chow SK; Chan JY; Fung KP
J Endocrinol; 2004 Aug; 182(2):325-37. PubMed ID: 15283693
[TBL] [Abstract][Full Text] [Related]
37. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
[TBL] [Abstract][Full Text] [Related]
39. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
[TBL] [Abstract][Full Text] [Related]
40. Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells.
Yang HS; Kim JY; Lee JH; Lee BW; Park KH; Shim KH; Lee MK; Seo KI
Food Chem Toxicol; 2011 Feb; 49(2):527-32. PubMed ID: 21134410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
